Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial Luis Paz‐Ares , Filippo de Marinis , Mircea Dediu +14 more 2012 The Lancet Oncology 605 citations